Intravenous neridronate infusions, administered quarterly, significantly increase BMD and lower the risk of clinical fracture in prepubertal children with OI
Background/Aims: To systematically assess contemporary knowledge regarding the effectiveness and saf...
Purpose Osteoporosis is a skeletal disorder characterized by reduced bone mass that results in incre...
Osteogenesis imperfecta is a genetic disorder of extracellular matrix, characterized with decreased ...
Introduction The present study assessed the long-term efficacy and safety of intravenous (i.v.) neri...
Cyclical neridronate treatment, started just after diagnosis at birth, had positive effects on growt...
Background: Osteogenesis imperfecta (OI) is a group of genetic diseases with a wide spectrum of seve...
Background: Osteogenesis imperfecta (OI) is a heritable disease marked by a varying degree of low bo...
Background: Osteogenesis imperfecta (OI) is a group of genetic diseases with a wide spectrum of seve...
Objective(s): To evaluate the effects of neridronate treatment on bone mass and vertebral deformitie...
Background: Osteogenesis Imperfecta (OI) is a rare, hereditary disorder that involves improper colla...
Objective To evaluate prospectively the efficacy of bisphosphonate treatment in infants with severe ...
Abstract Intravenous treatment with pamidronate is beneficial in children and adolescents with moder...
Background/Aims: To systematically assess contemporary knowledge regarding the effectiveness and saf...
Objective: To verify the effects of bisphosphonates (Bps) in combination with recombinant human grow...
OBJECTIVE: Evaluate clinical outcome of early cyclic intravenous pamidronate treatment in children w...
Background/Aims: To systematically assess contemporary knowledge regarding the effectiveness and saf...
Purpose Osteoporosis is a skeletal disorder characterized by reduced bone mass that results in incre...
Osteogenesis imperfecta is a genetic disorder of extracellular matrix, characterized with decreased ...
Introduction The present study assessed the long-term efficacy and safety of intravenous (i.v.) neri...
Cyclical neridronate treatment, started just after diagnosis at birth, had positive effects on growt...
Background: Osteogenesis imperfecta (OI) is a group of genetic diseases with a wide spectrum of seve...
Background: Osteogenesis imperfecta (OI) is a heritable disease marked by a varying degree of low bo...
Background: Osteogenesis imperfecta (OI) is a group of genetic diseases with a wide spectrum of seve...
Objective(s): To evaluate the effects of neridronate treatment on bone mass and vertebral deformitie...
Background: Osteogenesis Imperfecta (OI) is a rare, hereditary disorder that involves improper colla...
Objective To evaluate prospectively the efficacy of bisphosphonate treatment in infants with severe ...
Abstract Intravenous treatment with pamidronate is beneficial in children and adolescents with moder...
Background/Aims: To systematically assess contemporary knowledge regarding the effectiveness and saf...
Objective: To verify the effects of bisphosphonates (Bps) in combination with recombinant human grow...
OBJECTIVE: Evaluate clinical outcome of early cyclic intravenous pamidronate treatment in children w...
Background/Aims: To systematically assess contemporary knowledge regarding the effectiveness and saf...
Purpose Osteoporosis is a skeletal disorder characterized by reduced bone mass that results in incre...
Osteogenesis imperfecta is a genetic disorder of extracellular matrix, characterized with decreased ...